NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 703109 | Null | 0.0385613993886001 | 0.20173635 |
NSC 707982 | Null | 0.0385613993886001 | 0.2428102 |
NSC 708423 | Null | 0.0385613993886001 | 0.19782567 |
NSC 708559 | Benzeneacetamide, 3,4-dichloro-N-methyl-N-[3- [(methyl)[3-(1-pyrrolidinyl)propyl]amino]propyl]-, diethanedioate (dioxalate) | 0.0385613993886001 | 0.11120896 |
NSC 710716 | Null | 0.0385613993886001 | 0.12915258 |
NSC 723548 | Null | 0.0385613993886001 | 0.39958294 |
NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0385613993886001 | 0.27628918 |
NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0385613993886001 | 0.22871816 |
NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0385613993886001 | 0.028817136 |
NSC 733504 | Everolimus | 0.0385613993886001 | -0.14223923 |